Study shows cancers with high levels of the SLC7A11 gene may respond to glucose transporter inhibitor treatment UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER HOUSTON — New findings from researchers at The University of Texas MD Anderson Cancer Center about how some cancer cells become “addicted” to glucose could open up fresh approaches to...
